Author

Andreas Langer

NanoTemper Technologies (Germany)ORCID 0009-0000-6730-9035Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biophysics· 2 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Adrián Velázquez‐CampoyiD· 1 shared Alberto Anastacio AmarillaiD· 1 shared Alejandro Rojas‐FernándeziD· 1 shared Alessandra FeoliiD· 1 shared Alexander A. KhromykhiD· 1 shared Alexander Kai BuelliD· 1 shared Alexei Cuevas· 1 shared Alexis Kuntzmann· 1 shared

Activity by Year

2021-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

Adrián Velázquez‐CampoyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiophysicsbioRxivPreprintOct 28, 2026

In-Solution Measurements of Binding Kinetics and Thermodynamics by nano Temperature Alteration Kinetics

Andreas Langer, Christian Osseforth, Philipp Schramm…·Oscar Reinecke

This paper introduces nanoTAK, a method to measure fast binding kinetics and thermodynamics using spectral shifts, validated across DNA, protein-ligand, and PROTAC systems.

DOI 10.64898/2026.10.22.760345

experimental assay

𝕏 PostBluesky

BiophysicsbioRxivPreprintOct 13, 2026

Interlaboratory benchmarking of differential scanning fluorimetry reveals sources of variability in protein thermal stability parameters

Sébastien Brûlé, Maelenn Chevreuil, Osvaldo Burastero…·Bertrand D. E. Raynal

This study benchmarks DSF across labs, showing variability in thermal stability parameters due to instruments, workflows, and fluorescence readouts, with harmonization and centralized analysis improving consistency.

DOI 10.64898/2026.10.12.758416

experimental assaybenchmarking

𝕏 PostBluesky

Molecular BiologyScientific ReportsPeer-reviewedFeb 8, 2021

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity Nanobody.

Guillermo Valenzuela, Ronald Jara, Daniel Watterson…·Alejandro Rojas‐Fernández

The paper describes the development of a high-affinity Nanobody against SARS-CoV-2 RBD that neutralizes wild-type and D614G variants with nanomolar potency.

57 citations

proteomicsexperimental assay

𝕏 PostBluesky